Seizure outcome in 175 patients with juvenile myoclonic epilepsy - A long-term observational study

Epilepsy Research

Volumn 108, Issue 10, 2014, Pages 1817-1824

  Höfler, Julia ^a,b   Unterberger, Iris ^b   Dobesberger, Judith ^a,b   Kuchukhidze, Giorgi ^a,b   Walser, Gerald ^b   Trinka, Eugen ^a,b  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Generalized epilepsy; Juvenile myoclonic epilepsy; Prognosis; Seizure freedom

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; LAMOTRIGINE; PHENOBARBITAL; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE; ANTICONVULSIVE AGENT;

ABSENCE; ADOLESCENT; ADULT; ARTICLE; AUSTRIA; BRAIN INJURY; CHILD; COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAM; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCLONUS EPILEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; ONSET AGE; OUTCOME ASSESSMENT; PHOTOSENSITIVITY; RETROSPECTIVE STUDY; TONIC CLONIC SEIZURE; AGED; CROSS-SECTIONAL STUDY; MIDDLE AGED; MYOCLONIC EPILEPSY, JUVENILE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROGNOSIS; RECURRENT DISEASE; SEIZURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCLONIC EPILEPSY, JUVENILE; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SEIZURES; YOUNG ADULT;

EID: 84913582642     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2014.09.008     Document Type: Article

References (39)

1. Appleton R., Beirne M., Acomb B. Photosensitivity in juvenile myclonic epilepsy. Seizure 2000, 9:108-111.
2. Baykan B., Altindag E.A., Bebek N., Ozturk A.Y., Aslantas B., Gurges C., Baral-Kulaksizoglu I., Gokyigit A. Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsy. Neurology 2008, 70:2123-2129.
3. Camfield C.S., Camfield P.R. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology 2009, 73:1041-1045.
4. Canevini M.P., Mai R., Di Marco C., Bertin C., Minotti L., Pontrelli V., Saltarelli A., Canger R. Juvenile myclonic epilepsy of Janz: clinical observations in 60 patients. Seizure 1992, 1:291-298.
5. Chakravarty A., Mukherjee A., Roy D. Observations on juvenile myoclonic epilepsy amongst ethnic bengalees in West Bengal an Eastern Indian state. Seizure 2007, 16:134-141.
6. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:389-399. Commission on Classification and Terminology of the International League against Epilepsy.
7. Delgado-Escueta A.V., Enrile-Bacsal F. Juvenile myoclonic epilepsy of Janz. Neurology 1984, 34:285-294.
8. Delgado-Escueta A.V., Serratosa J.M., Medina M.T. Juvenile myoclonic epilepsy. The Treatment of Epilepsy: Principles and Practice 1997, 484-501. Williams & Wilkins, Baltimore. second ed. E. Wylie (Ed.).
9. Dreifuss F.E. Juvenile myoclonic epilepsy: characteristics of a primary generalised epilepsy. Epilepsia 1989, 30(Suppl. 4):S1-S7. (discussion S24-7).
10. De Araújo Filho G.M., Rosa V.P., Lin K., Caboclo L.O., Sakamoto A.C., Yacubian E.M. Psychiatric comorbidity in epilepsy: a study comparing patients with mesial temporal sclerosis and juvenile myoclonic epilepsy. Epilepsy Behav. 2008, 13:196-201.
11. Geithner J., Schneider F., Wang Z., Berneiser J., Herzer R., Kessler C., Runge U. Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up. Epilepsia 2012, 53:1379-1386.
12. Gelisse P., Genton P., Thomas P., Rey M., Samuelian J.C., Dravet C. Clinical factors of drug resistance in patients with juvenile myoclonic epilepsy. J. Neurol. Neurosurg. Psychiatry 2001, 70:240-243.
13. Genton P., Bauer J., Duncan S., Taylor A.E., Balen A.H., Eberle A., Pedersen B., Salas-Puig X., Sauer M.V. On the association between valproate and polycystic ovary syndrome. Epilepsia 2001, 42:295-304.
14. Gelisse P., Thomas P., Samuelian J.C., Gentin P. Psychiatric disorders in juvenile myoclonic epilepsy. Epilepsia 2007, 48:1032-1033.
15. Grünewald R.A., Panayiotopoulos C.P. Juvenile myoclonic epilepsy. A review. Arch. Neurol. 1993, 50:594-598.
16. Guaranha M.S.B., Filho G.M., Lin K., Guilhoto L.M., Caboclo L.O., Yacubian E.M. Prognosis of juvenile myoclonic epilepsy is related to entophenotypes. Seizure 2011, 20:42-48.
17. Hirsch E., Schmitz B., Carreño M. Epilepsy, antiepileptic drugs (AEDs) and cognition. Acta Neurol. Scand. Suppl. 2003, 180:23-32.
18. Isojärvi J.I., Laatikainen T.J., Pakarinen A.J., Juntunen K.T., Myllylä V.V. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N. Engl. J. Med. 1993, 329:1383-1388.
19. Jain S., Padma M.V., Maheshwari M.C. Occurrence of only myoclonic jerks in juvenile myoclonic epilepsy. Acta Neurol. Scand. 1997, 95:263-267.
20. Janz D., Christian W. Impulsive petit mal. Dtsch. Z. Nervenheilkd. 1957, 176:346-386.
21. Janz D. Die Epilepsien 1969, Thieme Medical Publishers, Stuttgart, Germany, (in German).
22. Janz D. Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy). Acta Neurol. Scand. 1985, 72:449-459.
23. Kasteleijn-Nolst Trenité D.G.A. Photosensitivity in epilepsy. Electrophysiological and clinical correlates. Acta Neurol. Scand. Suppl. 1989, 125:3-149.
24. Kasteleijn-Nolst Trenité D.G.A., de Weerd A., Beniczky S. Chronodependency and provocative factors in juvenile myoclonic epilepsy. Epilepsy Behav. 2013, 28(Suppl. 1):S25-S29.
25. Kleveland G., Engelsen B.A. Juvenile myoclonic epilepsy: clinical characteristics, treatment and prognosis in a Norwegian population of patients. Seizure 1998, 7:31-38.
26. Labate A., Ambrosio R., Gambardella A., Sturniolo M., Pucci F., Quattrone A. Usefulness of a morning routine EEG recording in patients with juvenile myoclonic epilepsy. Epilepsy Res. 2007, 77:17-21.
27. Luef G., Abraham I., Haslinger M., Trinka E., Seppi K., Unterberger I., Alge A., Windisch J., Lechleitner M., Bauer G. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women. J. Neurol. 2002, 249:835-841.
28. Luef G.J., Waldmann M., Sturm W., Naser A., Trinka E., Unterberger I., Bauer G., Lechleitner M. Valproate therapy and nonalcoholic fatty liver disease. Ann. Neurol. 2004, 55:729-732.
29. Martinez-Juarez I.E., Alonso M.E., Medina M.T., Du Ron R.M., Bailey J.N., Lopez-Ruiz M., Ramos-Ramirez R., Leon L., Pineda G., Castroviejo I.P., Silva R., Mija L., Perez-Gosiengfiao K., Machado-Salas J., Delgado-Escueta A.V. Juvenile myoclonic epilepsy subsyndromes: family studies and longterm follow-up. Brain 2006, 129:1269-1280.
30. Meador K.J. To stop or not to stop the AED?. Epilepsy Curr. 2008, 8:90-91.
31. Panayiotopoulos C.P., Obeid T., Tahan A.R. Juvenile myoclonic epilepsy: a 5 year prospective study. Epilepsia 1994, 35:285-296.
32. Penry J.K., Dean J.C., Riela A.R. Juvenile myoclonic epilepsy: long-term response to therapy. Epilepsia 1989, 30(Suppl 4):S19-S23. (discussion 24-7).
33. Perini G.I., Tosin C., Carraro C., Bernasconi G., Canevini M.P., Canger R., Pellegrini A., Testa G. Interictal mood and personality disorders in temporal lobe epilepsy and juvenile myoclonic epilepsy. J. Neurol. Neurosurg. Psychiatry 1996, 61:601-605.
34. Rinnerthaler M., Luef G., Mueller J., Seppi K., Wissel J., Trinka E., Bauer G., Poewe W. Computerized tremor analysis of valproate-induced tremor: a comparative study of controlled-release versus conventional valproate. Epilepsia 2005, 46:320-323.
35. Scollo-Lavizzari G., Scollo-Lavizzari G.R. Sleep, sleep deprivation, photosensitivity and epilepsy. Eur. Neurol. 1974, 11:1-21.
36. Senf P., Schmitz B., Holtkamp M., Janz D. Prognosis of juvenile myoclonic epilepsy 45 years after onset: seizure outcome and predictors. Neurology 2013, 81:2128-2133.
37. Shinnar S., Berg A.T., Moshé S.L., Kang H., O'Dell C., Alemany M., Goldensohn E.S., Hauser W.A. Discontinuing antiepileptic drugs in children with epilepsy: a prospective study. Ann. Neurol. 1994, 35:534-545.
38. Teich M., Longin E., Dempfle C.E., König S. Factor XIII deficiency associated with valproate treatment. Epilepsia 2004, 45:187-189.
39. Trinka E., Kienpointner G., Unterberger I., Luef G., Bauer G., Doering L.B., Doering S. Psychiatric comorbidity in juvenile myoclonic epilepsy. Epilepsia 2006, 47:2086-2091.